Pharma Co. Hid Cancer Study Method Problems, Investor Claims

Biotechnology company UroGen Pharma Ltd. and three current and former executives are facing a proposed investor class action in New Jersey federal court alleging the company failed to disclose methodology flaws...

Already a subscriber? Click here to view full article